Clinical Trial Detail

NCT ID NCT01664754
Title Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Pemetrexed Disodium

Carboplatin

Exemestane

Age Groups: adult

No variant requirements are available.